BACKGROUND: The formation and accumulation of advanced glycation end products (AGE) in various tissues are known to be involved in the aging process and complications of long-term diabetes. Aminoguanidine as AGE inhibitors was first studied, and metformin as biguanide compounds have been reported to react with reactive dicarbonyl precursors such as methylglyoxal. METHODS: We studied the effects of the biguanides of buformin and metformin on AGE formation by the methods of specific fluorescence, and enzyme-linked immunosorbent assay and a Western blot analysis using the anti-AGE antibody after incubating BSA or RNase with methylglyoxal. RESULTS: Buformin is a more potent inhibitor of AGE formation than metformin, and suggests that the amino group of buformin trap the carbonyl group of methylglyoxal to suppress formation of AGE. CONCLUSION: In addition to that of metformin, buformin may be clinically useful to prevent diabetic complications.
BACKGROUND: The formation and accumulation of advanced glycation end products (AGE) in various tissues are known to be involved in the aging process and complications of long-term diabetes. Aminoguanidine as AGE inhibitors was first studied, and metformin as biguanide compounds have been reported to react with reactive dicarbonyl precursors such as methylglyoxal. METHODS: We studied the effects of the biguanides of buformin and metformin on AGE formation by the methods of specific fluorescence, and enzyme-linked immunosorbent assay and a Western blot analysis using the anti-AGE antibody after incubating BSA or RNase with methylglyoxal. RESULTS:Buformin is a more potent inhibitor of AGE formation than metformin, and suggests that the amino group of buformin trap the carbonyl group of methylglyoxal to suppress formation of AGE. CONCLUSION: In addition to that of metformin, buformin may be clinically useful to prevent diabetic complications.
Authors: Owen R Kinsky; Tiffanie L Hargraves; Tarun Anumol; Neil E Jacobsen; Jixun Dai; Shane A Snyder; Terrence J Monks; Serrine S Lau Journal: Chem Res Toxicol Date: 2016-01-27 Impact factor: 3.739
Authors: Adriana M Capucho; Ana Chegão; Fátima O Martins; Hugo Vicente Miranda; Sílvia V Conde Journal: Nutrients Date: 2022-03-29 Impact factor: 5.717
Authors: Eunjin Sohn; Junghyun Kim; Chan-Sik Kim; Yun Mi Lee; Kyuhyung Jo; So Dam Shin; Joo Hwan Kim; Jin Sook Kim Journal: Evid Based Complement Alternat Med Date: 2013-05-27 Impact factor: 2.629